AKT3 and schizophrenia: Moreover, recent investigations testing for enrichment of the 108 schizophrenia-risk loci, and overlapping rare singleton disruptive mutations in gene sets coding for proteins targeted by antipsychotic drugs, identified AKT3 as a potential target gene of relevance to antipsychotic treatment and response [7].